Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Cold And Flu Drugs Market Growth in 2025?

Recent years have witnessed a swift expansion of the cold and flu drugs market. The market is projected to expand from $17.35 billion in 2024 to $19.19 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.6%. Factors such as an increasing aging populace, growing acceptance of over-the-counter (OTC) drugs, increasing urbanization, a surge in demand for herbal and organic remedies along with an uptick in healthcare spending have contributed to the historic growth rate.

What Is the Forecast for the Cold And Flu Drugs Market Size Through 2029?

The market for cold and flu drugs is forecasted to experience a swift expansion in the following years, projecting a value of $28.54 billion in 2029 with a compound annual growth rate (CAGR) of 10.4%. Various factors are contributing to this expansion in the forecast period, including the growing incidence of seasonal influenza, escalating air pollution that leads to respiratory infections, an uptick in antibiotic resistance cases, an increasing inclination towards supplements that boost immunity, and heightened consciousness about self-drug management. Key developments during this forecast period include personalized medicine, the creation of combination products and natural remedies, improvements in nasal sprays and inhalers, strategic collaborations and the development of fast-acting drug formulations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23344&type=smp

What are the Key Market Players in Cold And Flu Drugs Market and How They’re Evolving?

Major companies operating in the cold and flu drugs market are Johnson & Johnson, Roche Holding AG, Bayer AG, Sanofi S.A., Viatris Inc., Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Pyxus International Inc., Glenmark Pharmaceuticals Ltd., The Kroger Co., Saphnix Life Sciences, Arlak Biotech Pvt Ltd, AdvaCare Pharma, Sterling Pharmaceuticals, Biophar Lifesciences Pvt Ltd, Nutra Respiro

What Are the Primary Growth Drivers in the Cold And Flu Drugs Market?

The surge in viral infections is projected to fuel the expansion of the cold and flu drugs market. Viral infections are diseases triggered by viruses that infiltrate and reproduce in host cells, leading to a range of symptoms. The upswing in viral infections can be attributed to increasing travel, resulting in the transmission of viruses across various regions and nations, enabling them to infiltrate new communities and cause epidemics. Cold and flu medications manage these viral infections by alleviating symptoms like fever, congestion, and pain, offering comfort while the body’s defense mechanism fights off the virus. Notably, in January 2025, the Pan American Health Organization, a US-based institution handling international health collaboration in the Americas, reported a global influenza positivity rate of 22.05% at the beginning of the year, marking a 20% seasonal surge. Thus, the rising prevalence of viral infections is a major factor propelling the growth of the cold and flu drugs market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=23344&type=smp

What Are the Leading Segments in the Global Cold And Flu Drugs Industry?

The cold and flu drugs market covered in this report is segmented –

1) By Type: Antihistamines, Expectorants, Bronchodilators, Decongestants, Other Types

2) By Dosage Form: Tablets, Capsules, Syrups, Lozenges, Other Dosage Forms

3) By Indication: Congenital Pituitary Dwarfism, Acquired Pituitary Dwarfism, Genetic Syndromes, Other Hormonal Disorders

4) By Age Group: Pediatric Patients, Adolescent Patients, Adult Patients, Geriatric Patients

5) By End-User: Hospitals, Specialized Clinics, Homecare Settings, Pharmaceuticals And Research Institutions

Subsegments:

1) By Type: First-Generation Antihistamines, Second-Generation Antihistamines, Combination Antihistamines

2) By Type: Guaifenesin-Based Expectorants, Herbal Expectorants, Combination Expectorants

3) By Type: Beta-Agonists, Anticholinergics, Combination Bronchodilators

4) By Type: Oral Decongestants, Nasal Spray Decongestants, Combination Decongestants

5) By Type: Pain Relievers, Cough Suppressants, Antipyretics, Nasal Sprays, Immune Boosters

What Are the Key Market Trends in the Cold And Flu Drugs Industry?

Leading businesses in the cold and flu drugs sector are shifting their focus towards creating innovative offerings such as clean over-the-counter (OTC) remedies. These aim to offer children a safer, natural alternative to traditional medicines that often contain artificial additives. The category of OTC medicines refers to those drugs that are available for purchase without a prescription and are commonly used in treating routine ailments like headaches, colds, and minor discomforts. Genexa Inc., a U.S.-based clean medicine manufacturer, for example, launched clean OTC children’s remedies in September 2023. These included the Kids’ Multi-Symptom Cold & Flu and Kids’ Daytime + Nighttime Cough Relief Value Pack. Composed of effective active components devoid of artificial colorants, sweeteners, or preservatives, these products present a safer and more natural option for treating children’s cold and flu symptoms. Additionally, they improve relief from conditions such as fever, sore throat, and congestion.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cold-and-flu-drugs-global-market-report

What Is the Regional Outlook for the Cold And Flu Drugs Market?

North America was the largest region in the cold and flu drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cold and flu drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23344

This Report Delivers Insight On:

1. How big is the cold and flu drugs market, and how is it changing globally?

2. Who are the major companies in the cold and flu drugs market, and how are they performing?

3. What are the key opportunities and risks in the cold and flu drugs market right now?

4. Which products or customer segments are growing the most in the cold and flu drugs market?

5. What factors are helping or slowing down the growth of the cold and flu drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model